tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market

Medicenna Therapeutics Corp (MDNAF) Income Statement

Compare
253 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q3 2026), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Medicenna Therapeutics Corp's net income was C$-4.36M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -55.00KC$ -5.00KC$ -38.00KC$ -40.00K-
Operating Expenses
C$ 21.58MC$ 19.66MC$ 22.47MC$ 17.39MC$ 8.24M
Depreciation and Amortization
C$ 55.00KC$ 5.00KC$ 38.00KC$ 40.00K-
EBITDA
C$ -12.97MC$ -18.67MC$ -22.54MC$ -17.25MC$ -8.27M
Operating Income
C$ -21.63MC$ -19.66MC$ -22.30MC$ -17.19MC$ -8.21M
Other Income/Expenses
C$ 8.60MC$ -5.80MC$ 1.65MC$ 106.00KC$ 919.00K
Pretax Income
C$ -13.03MC$ -25.47MC$ -22.58MC$ -17.29MC$ -8.28M
Net Income
C$ -11.80MC$ -25.47MC$ -22.65MC$ -17.18MC$ -8.31M
Per Share Metrics
Basic EPS
C$ -0.15C$ -0.37C$ -0.42C$ -0.35C$ -0.26
Diluted EPS
C$ -0.15C$ -0.37C$ -0.42C$ -0.35C$ -0.26
Weighted Average Shares Outstanding
76.67M 69.64M 54.29M 49.66M 31.90M
Weighted Average Shares Outstanding (Diluted)
76.67M 69.64M 54.29M 49.66M 31.90M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History